Latus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
Develops purpose-built networking silicon and systems for AI data centers and hyperscalers
Develops AI-powered imaging tools for stroke and lung fibrosis
Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease
Develops AI-driven drug discovery for proximity therapeutics
Pitching Modi Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room